Quantcast
RSS

Oracle Buys Drug-design Software Maker's IP

Oracle on Wednesday said it has bought the intellectual property of Conformia Software, maker of software for managing the design and development of drugs. Terms of the deal were not disclosed.

Oracle plans to integrate Conformia's technology into its own PLM (product lifecycle management) offering, as well as tie it into other Oracle applications and third-party sources, the company said in a statement.

While likely modest, especially compared to its pending deal to buy Sun Microsystems, Oracle's latest move fits into its larger strategy of pursuing vertical markets in search of growth.

Meanwhile, Conformia has had ties to Oracle's rival, SAP. The latter's NetWeaver Fund made an investment in Conformia in 2007, according to an SAP press release.

Was this article useful? Yes 0 No 0
Add Yours

Comments Readers reply with their ideas and expertise.

Subscribe to this discussion via email or RSS
  • What do you think?

Get the job done
-- from anywhere

Access hard-to-reach devices. Avoid going onsite.
Be alerted of issues.

Business News Daily

Get the latest technology news that's important to you and your business, fresh seven days a week.

Featured Webcasts

Free Whitepapers

Software and Services Whitepapers from PC World

More whitepapers »

Whitepaper Alerts

Get updates on white papers, case studies, and spotlights on tech products and solutions for your business.

PC World's Marketplace

Sponsored Links